Live Breaking News & Updates on Philip Nadeau

Stay updated with breaking news from Philip nadeau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

New Zealand , United States , Salveen Richter , Charlie Wagner , Geoff Meacham , Jessica Fye , Philip Nadeau , Charles Wagner , Susie Lisa , Reshma Kewalramani , Terence Flynn , Evan Seigerman , Stuart Arbuckle , Phil Nadu , Colin Bristow , Morgan Stanley , Alpine Immune Sciences , Vertex Pharmaceuticals Inc Ma , Goldman Sachs , American Diabetes Association Annual Meeting , Vertex Pharmaceuticals Incorporated , Exchange Commission , Vertex Pharmaceuticals First Quarter , Call Transcript May , Pharmaceuticals Incorporated , Senior Vice President ,

Galapagos NV (NASDAQ:GLPG) Q1 2024 Earnings Call Transcript

Sofie Van Gijsel: Welcome all to the audio webcast of Galapagos Q1 2024 Results. I m Sofie Van Gijsel, Investor Relations representing the reporting team at Galapagos. ....

United States , New Jersey , Brian Abrahams , Paul Stoffels , Judah Frommer , Nevin Varghese , Jeevan Shetty , Thad Huston , Philip Nadeau , Van Gijsel , Thermo Fisher , Head Of Development Oncology , Morgan Stanley , Richest Billionaires In Technology Industry , Call Transcript May , Im Sofie Van Gijsel , Investor Relations , Landmark Bio , Technology Industry , Self Help Books , Women According , Xian Deng , Bay Area , Cell Shuttle ,

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2022 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Fourth Quarter and Full Year 2022 Earnings Conference Call. ....

United States , United Kingdom , Dave Connolly , Yann Mazabraud , Piet Wigerinck , Jennifer Chien , David Meeker , Philip Nadeau , Hunter Smith , David Connolly , America Team Meeting , International Patient Organization , Generation Battery Technology Companies , Head Of International , Rhythm Pharmaceuticals , Rhythm Pharmaceuticals Inc , Corporate Communications , Health Photo , Rhythm Pharmaceuticals Fourth Quarter , Most Profitable Energy Stocks , Call Transcript March , Full Year , Executive Director , Investor Relations , Im Dave Connolly , Chief Executive Officer ,

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2022 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Third Quarter 2022 Earnings Conference Call. ....

United States , United Kingdom , Pais Vasco , Dave Connolly , Peter Kennan , Yann Mazabraud , Sadaf Farooqi , Philip Nadeau , Jennifer Chien , David Meeker , Hunter Smith , David Connolly , Corporate Communications At Rhythm Pharmaceuticals , Head Of International , University Medical Center , European Rare Disease Center , Rhythm Pharmaceuticals Inc , Corporate Communications , National Cancer Institute On Unsplash , Rhythm Pharmaceuticals Third Quarter , Patient Association , Rhythm Pharmaceuticals , Call Transcript November , Investor Relations , National Cancer Institute , Chief Executive Officer ,

Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2022 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. (NASDAQ:NASDAQ:RYTM) Q3 2022 Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants David Connolly - Investor Relations and Corporate. ....

United Kingdom , United States , Pais Vasco , Dave Connolly , Peter Kennan , Yann Mazabraud , Michael Higgins , Sadaf Farooqi , Corinne Jenkins , David Meeker , Jennifer Chien , Philip Nadeau , David Connolly , Hunter Smith , Morgan Stanley , Company Participants , Corporate Communications At Rhythm Pharmaceuticals , Head Of International , University Medical Center , Goldman Sachs , European Rare Disease Center , Needham Company , Rhythm Pharmaceuticals Inc , Corporate Communications , Patient Association , Rhythm Pharmaceuticals Third Quarter ,